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THE TEXAS ORAL RABIES VACCINATION PROJECT AND THE EXPERIMENTAL USE
OF RABORAL V-RG RABIES VACCINE IN THE SOUTH TEXAS COYOTE RABIES
EPIZOOTIC
M. GAYNE FEARNEYHOUGH, Oral Rabies Vaccination Program Zoonosis Control Division, Texas Department
of Health, 1100 West 49th Street, Austin, Texas 78756.
Proc. 17th Vertebr. Pest Conf. (R.M. Timm & A.C. Crabb,
Eds.) Published at Univ. of Calif., Davis. 1996.
Beginning in October 1988, Texas experienced the
onset of an expanding epizootic of canine rabies in South
Texas. That epizootic now involves 21 counties, with 678
laboratory confirmed cases as of February 1996.
Approximately 50% of those cases have occurred in
coyotes and most of the remainder in domestic dogs.
Seventy-six "spill over" cases have been reported in seven
other species, both wild and domestic. Since 1991, over
2,000 people in South Texas have received post exposure
rabies treatment due to potential exposure to a rabid
animal and two human deaths have been attributed to this
virus strain. The Texas Department of Health (TDH) is
the lead agency in the development of an experimental
program designed to explore use of an oral rabies
vaccine, Raboral V-RG, produced by Rhone-Merieux,
Inc. in Athens, Georgia. The Oral Rabies Vaccination
Program (ORVP) is an innovative cooperative project
involving the TDH; Texas Animal Damage Control; U.S.
Department of Agriculture (USDA); Texas A&M
University-College Station; Texas A&M University-
Kingsville; Centers for Disease Control and Prevention,
Denver Wildlife Research Center; USDA Predator
Research Center at Logan, Utah; Texas National Guard,
U.S. Army; Canadian Ministry of Natural Resources; and
Rhone-Merieux, Inc.
The objective of the first year of the program was to
determine the feasibility of using Raboral V-RG oral
rabies vaccine, delivered in a bait to coyotes, as a method
of controlling the northward expansion of the South Texas
rabies epizootic. Field application of the vaccine was
with vaccine/bait combinations containing 2 milliliters of
Raboral V-RG vaccine at a minimum field dosage of
107.4 virus particles in a plastic container (a sachet)
enclosed in a hollow extruded bait. The long term
program strategy is to be conducted over the next four to
five years, and has the goal of pushing the epizootic
southward and eliminating it from Texas.
The program was first conducted in February 1995
and resulted in the deployment of 830,000 doses of oral
rabies vaccine over 15,000 acres of South Texas. The
1995 program was successful not only in the logistical
accomplishment, but post-drop surveillance programs
demonstrated a dramatic reduction in rabies in the
targeted area. Evaluation of the program to date has been
based on three parameters: 1) epidemiologic evidence
of containment of the virus in its present location;
2) identification of marking agents that determine uptake
of the bait in coyotes from the baited area; and
3) evidence of change in the immune status in a
representative sample of the coyote population in the
baited area. The program has shown significant success
in all three of these areas. The expansion of the rabies
outbreak not only has been halted but, with the exception
of an isolated area in Atascosa County, cases of canine
rabies have ceased to be reported in the primary 40-mile
wide baited zone. Evidence of bait uptake has exceeded
expectations with 68% of one- to three-year old animals
having eaten an average of 2.6 baits each. Studies
indicating the immune status of coyotes from the baited
area revealed evidence of immune response in 49% of the
coyotes eating baits. Therefore, by all measures of
success, the program has met or exceeded expectations.
The success of the first year was a prelude to a larger,
and hopefully more successful, 1996 program.
In the short time period of 31 days, beginning on
January 4, the participants of the 1996 program aerially
distributed more than 2.5 million doses of vaccine over
41,679 square miles of Texas. This has been the world's
largest single application of an oral rabies vaccine and
involved 276 separate flights of three "Twin Otter"
aircraft provided through an agreement with the Ontario
Ministry of Natural Resources. The 1996 program was
flown from four airports and resulted in a total flight
distance equaling more than four trips around the world.
This accomplishment was due, in large part, to a unique
spirit of cooperation from all agencies and individuals
participating.
The successful completion of this program will have
a significant long term impact on public health programs
in the United States. Not only does this program
represent the best approach for obvious human health
reasons, but it will also save health care dollars, is a
nonlethal solution to a wildlife disease problem, and will
yield information that may provide answers to future
wildlife disease and management questions.
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